AI could revolutionize cancer diagnosis in new study
NCT ID NCT07269236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new artificial intelligence (AI) system that combines information from tissue samples, scans, and medical records to help doctors better diagnose and treat cancer. Researchers will enroll 2000 adults with various cancers to see how well the AI can classify tumors, predict treatment responses, and support personalized care. The goal is to speed up the use of AI in everyday cancer care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Zhongshan City People's Hospital
Zhongshan, Guangdong, 513000, China